HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maximilian Diehn Selected Research

Etanidazole

11/201818F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy.
10/2010Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maximilian Diehn Research Topics

Disease

93Neoplasms (Cancer)
11/2022 - 06/2002
34Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 05/2011
18Lung Neoplasms (Lung Cancer)
01/2022 - 12/2012
9Neoplasm Metastasis (Metastasis)
11/2022 - 08/2015
7Residual Neoplasm
12/2021 - 10/2015
6Breast Neoplasms (Breast Cancer)
01/2017 - 02/2008
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2021 - 06/2015
5Adenocarcinoma of Lung
10/2021 - 01/2017
5Adenocarcinoma
05/2020 - 06/2017
4Disease Progression
10/2020 - 07/2014
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2020 - 01/2017
4Tics (Tic)
08/2015 - 01/2014
3Prostatic Neoplasms (Prostate Cancer)
01/2020 - 06/2002
3Dyspnea (Shortness of Breath)
11/2019 - 09/2014
2Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 12/2020
2Sarcoma (Soft Tissue Sarcoma)
10/2021 - 12/2020
2Pneumonia (Pneumonitis)
01/2021 - 01/2020
2Glioma (Gliomas)
12/2020 - 01/2014
2COVID-19
01/2020 - 01/2020
2Hypoxia (Hypoxemia)
11/2018 - 10/2010
2Circulating Neoplastic Cells
06/2017 - 12/2016
2Emphysema
03/2016 - 09/2014
2Esophagitis
03/2016 - 09/2015
2Radiation Pneumonitis
01/2016 - 07/2014
2Head and Neck Neoplasms (Head and Neck Cancer)
11/2014 - 08/2014
2Carcinogenesis
02/2014 - 06/2002
1Malignant Pleural Effusion
11/2022
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2021
1Rectal Neoplasms (Rectal Cancer)
12/2020
1Pain (Aches)
01/2020
1Esophageal Neoplasms (Esophageal Cancer)
01/2020
1Respiratory Insufficiency (Respiratory Failure)
11/2019
1Autoimmune Diseases (Autoimmune Disease)
11/2019
1Melanoma (Melanoma, Malignant)
01/2019
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2019
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2019
1Radiation Fibrosis Syndrome (Radiation Fibrosis)
01/2018
1Fibrosis (Cirrhosis)
01/2018
1Leiomyosarcoma
01/2018
1Margins of Excision
11/2017
1Sick Sinus Syndrome
11/2017

Drug/Important Bio-Agent (IBA)

25Circulating Tumor DNAIBA
05/2022 - 05/2014
18DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2002
17Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2014
8Cell-Free Nucleic AcidsIBA
01/2022 - 11/2016
5RNA (Ribonucleic Acid)IBA
12/2020 - 07/2014
4Biological ProductsIBA
10/2021 - 06/2002
4AntigensIBA
01/2021 - 01/2002
3Proteins (Proteins, Gene)FDA Link
01/2021 - 02/2002
3ErbB Receptors (EGF Receptor)IBA
01/2019 - 10/2016
3GoldIBA
01/2017 - 09/2011
3Estrogen ReceptorsIBA
01/2017 - 11/2003
2Tyrosine Kinase InhibitorsIBA
01/2021 - 01/2019
2osimertinibIBA
01/2021 - 01/2021
2durvalumabIBA
01/2021 - 01/2021
2EpitopesIBA
01/2021 - 11/2019
2Peptides (Polypeptides)IBA
01/2021 - 11/2019
2Immune Checkpoint InhibitorsIBA
10/2020 - 01/2019
2Hormones (Hormone)IBA
01/2020 - 06/2017
2AndrogensIBA
01/2020 - 06/2002
2Oxygen (Dioxygen)IBA
11/2019 - 04/2009
2EtanidazoleIBA
11/2018 - 10/2010
2EnzymesIBA
01/2018 - 01/2014
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2017 - 04/2008
2Immunoglobulins (Immunoglobulin)IBA
11/2016 - 06/2015
2Fluorine-18IBA
11/2015 - 07/2014
2PlatinumIBA
03/2013 - 09/2011
1ChromatinIBA
01/2022
1Flucytosine (Ancobon)FDA Link
12/2020
1vocimagene amiretrorepvecIBA
12/2020
1GlutaminaseIBA
12/2020
1NucleotidesIBA
01/2020
1VaccinesIBA
11/2019
1HLA Antigens (Human Leukocyte Antigens)IBA
11/2019
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2019
1CrizotinibIBA
01/2019
1cabozantinibIBA
01/2019
1Complement System Proteins (Complement)IBA
01/2019
1NitroimidazolesIBA
11/2018
1carbogenIBA
11/2018
1Transaminases (Aminotransferases)IBA
01/2018
1HexosaminesIBA
01/2018
1Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)IBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1Mutant Proteins (Protein, Mutant)IBA
12/2017
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
06/2017
1Carboplatin (JM8)FDA LinkGeneric
01/2017

Therapy/Procedure

48Radiotherapy
01/2022 - 12/2006
40Therapeutics
11/2022 - 01/2006
6Drug Therapy (Chemotherapy)
05/2022 - 02/2014
6Immunotherapy
09/2021 - 12/2016
6Aftercare (After-Treatment)
01/2020 - 10/2015
3Precision Medicine
10/2021 - 01/2017
3Chemoradiotherapy
01/2020 - 11/2016
3Re-Irradiation
03/2016 - 09/2012
2Consolidation Chemotherapy
01/2017 - 01/2017
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
11/2016 - 12/2013
2Pneumonectomy (Lung Volume Reduction)
03/2016 - 09/2014
1Surgical Instruments (Clip)
01/2020
1Neoadjuvant Therapy
11/2017